Fecal microbiota tRAnspLantation uSed TO improve postpraNdial bacterIAl translocation;<br>the RALSTONIA study.
- Conditions
- insulin resistancemetabolic syndrome10018424
- Registration Number
- NL-OMON47262
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 36
Metabolic syndrome patients:
- Caucasian
- BMI >25 kg/m2
- At least 3 out of 5 NCEP metabolic syndrome criteria: fasting plasma glucose *5.6 mmol/l, triglycerides *1.7 mmol/l, waist-circumference >102 cm, HDL-cholesterol 1.04 mmol/l, blood pressure *130/85 mmHg
- Scheduled for laparoscopic cholecystectomy or laparoscopic gastric bypass;Lean donors:
- BMI 18,5-25 kg/m2
Metabolic syndrome patients:
- A history of cardiovascular event (cerebrovascular accident, myocardial infarction or pacemaker implantation)
- Use of any medication including proton pump inhibitors and antibiotics in the past three months
- (Expected) prolonged compromised immunity (due to recent cytotoxic chemotherapy or HIV infection with a CD4 count < 240/mm3)
- Type 2 diabetes mellitus
- Smoking;Lean donors:
- Use of any medication including proton pump inhibitors and antibiotics in the past 3 months
- Type 2 diabetes mellitus
- Diarrhea
- Cholecystectomy
- HIV, HAV, HBV, HCV, active CMV, active EBV
- Unsafe sex practice (questionnaire)
- Illicit drug use
- Smoking
- Presence of fecal bacterial pathogens (Salmonella, Shigella, Campylobacter, Yersinia) or parasites
- Positive C. difficile stool test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To investigate whether an oral fat load induces translocation of intestinal<br /><br>bacteria including Ralstonia picket and whether lean donor fecal<br /><br>transplantation affects this.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To investigate whether changes in (small) intestinal gut microbiota are related<br /><br>to postprandial bacterial translocation. Moreover, we will investigate changes<br /><br>in visceral and subcutaneous adipose tusse and plasma. Furthermore, we will<br /><br>study changes in 24h feces (triglyceride excretion) and 24h urine (TMAO and<br /><br>oxalic acid).</p><br>